NASA Selects Blue Origin Over SpaceX for Critical Moon Base Mission Disneys Star Wars The Mandalorian and Grogu Opens to Weakest Thursday Previews in Series History Signos Secures 20 Million Funding with Dexcom Partnership to Advance AIPowered Health Tracking Amid GLP1 Weight Loss Trend Indias Tax Administration Overhaul Planned for Seamless GST Rollout Michael Price Advocates Contrarian Investing to Navigate Market Volatility ADP Data Shows Private Payrolls Beat Expectations in April Signaling Labor Market Resilience WDH Q3 2025 Earnings EPS Beats Estimates by 649 Amid Steep Stock Decline CARE Q1 2026 Earnings Major EPS Disappointment Belies Surprising Stock Stability BMM Q1 2026 Earnings Stunning EPS Beat Delivers 042 Against Negative Expectations MED Q1 2026 Earnings NarrowerThanExpected Loss Signals Operational Resilience PLAG Q3 2023 Earnings EPS of 002 Reports Loss Revenue Not Disclosed TRTX Q1 2026 Earnings EPS Falls Short of Estimates Amid Narrow Miss KF Growth Acquisition Corp II KFII Holds Steady Near Trust Value as SPAC Consolidation Continues Sify Technologies SIFY Surges 254 as Stock Holds Above Key Support GIII Apparel Group GIII Rises 28 as Stock Approaches Key Resistance Level Diversified Healthcare Trust DHC Slips 169 Navigating Key Support Levels FFIC Slips 075 as Investors Await Clearer Direction AIPowered RealTime Feedback Reshapes Customer Experience Analytics Market USFD Q1 2026 Earnings Earnings Miss Estimates Amid Challenging Environment RF Acquisition Corp II Rights RFAIR Hold Steady at 010 Amid Low Trading Activity Lite Strategy Inc LITS Slides 273 as Selling Pressure Mounts Near Key Support High Templar Tech HTT Posts Modest Gain Consolidating Near Key Support StoneBridge Acquisition II Corporation APAC Holds Steady at 1012 SPAC Trading in a Tight Range Comfort Systems USA FIX Edges Higher Maintaining Uptrend Amid Key Resistance Test BlackRock Virginia Municipal Bond Trust BHV Posts 119 Gain Approaching Key Resistance Keysight Technologies KEYS Holds Above Support After Measured Gain Neumora Therapeutics NMRA Edges Higher Testing Key Resistance Levels